# Shoulder treatment words need clear meanings *Plain treatment words | shoulder regeneration scottsdale* > Plain meanings for PRP and regenerative medicine Scottsdale choices, plus useful questions about the treatment, price, and time. ## PRP is a treatment prepared from your blood What is PRP? The letters mean platelet-rich plasma, a treatment made during your visit from a blood draw. Blood goes into a machine that separates liquid holding extra platelets. There's no need to choose care before the clinic explains what will be placed near your shoulder. ## PRP mixes can differ from clinic to clinic The finished PRP contains liquid and platelets from your own blood. Some preparations include many white blood cells, while others include few. Because clinics can process blood differently, one PRP treatment may hold many white blood cells while another holds few, so finished mixes may not match closely from place to place. Those choices explain why the final mixes aren't identical. Ask whether the offered PRP has more or fewer white blood cells. Then ask why that mix was chosen for your shoulder. I'd ask which side effects were reported with that same kind of PRP. Clear answers matter before paying or setting aside recovery time. ## A clear treatment answer names the material and goal Regenerative treatments can use blood or material taken elsewhere in the body. On this site, the named choice is concentrated PRP from your blood. The word doesn't promise that a worn tendon or joint becomes new. Less soreness or easier movement may be a more useful goal. Ask, “What change could I notice, and when would I notice it?” Also ask which care comes next if you still hurt. Simpler care, such as exercise or changing a painful task, may still matter. QC Kinetix has medical providers who check your shoulder and discuss non-surgical biologic therapies, including concentrated PRP made from blood. ## Sources 1. Arnold Caplan, who NAMED mesenchymal stem cells more than 25 years earlier, argued in Stem Cells Translational Medicine that the name should be changed. His stated reason is exactly the marketing problem: because MSCs are called 'stem cells', patients infer they will receive direct medical benefit, imagining the cells will differentiate into regenerating tissue-producing cells - and hundreds of clinics and trials now use human MSCs with very few focusing on the in vitro multipotential capacities the name refers to. Caplan AI, et al. — [Mesenchymal Stem Cells: Time to Change the Name!](https://pubmed.ncbi.nlm.nih.gov/28452204/). *Stem cells translational medicine*, 2017. DOI: 10.1002/sctm.17-0051. 2. A Nature comment by Sipp, Robey and Turner arguing that loose use of 'mesenchymal stem cell' across an enormous range of unrelated cell preparations has produced a scientific and commercial mess, and calling for the terminology and the evidentiary standards to be tightened. Included because the objection to the word comes from inside stem cell science, not from its critics. Sipp D, et al. — [Clear up this stem-cell mess.](https://pubmed.ncbi.nlm.nih.gov/30258150/). *Nature*, 2018. DOI: 10.1038/d41586-018-06756-9. 3. A Level-1a systematic review of 87 randomized PRP-for-knee-OA trials (7,925 patients, 8,118 knees) scored them against the 23-item MIBO reporting checklist. The overall MIBO score was 72%, 71% of studies scored below 80%, and reporting was worst on exactly the items that define the product: whole-blood characteristics (20%), platelet recovery rate (22%), PRP analysis (30%), PRP activation (47%). Adherence did not improve after MIBO was published. Much of the PRP literature does not say what was actually injected. Nakagawa HF, et al. — [Systematic Review of Randomized Controlled Trials Evaluating the Use of Platelet-Rich Plasma for Knee Osteoarthritis: Adherence to Minimum Information for Studies Evaluating Biologics in Orthopaedics.](https://pubmed.ncbi.nlm.nih.gov/39754417/). *The American journal of sports medicine*, 2025. DOI: 10.1177/03635465241249996. 4. A JBJS systematic review screened 420 papers on intra-articular cellular therapy for knee OA and focal cartilage defects and found only SIX at Level III evidence or higher (4 Level II, 2 Level III), covering 300 knees, with wide variation in cell source, cell characterisation, adjuvant therapy and outcome assessment - meaning no consensus exists on indications, cell sources, preparation or delivery. Two products called 'stem cell therapy' at two clinics may share almost nothing. Chahla J, et al. — [Intra-Articular Cellular Therapy for Osteoarthritis and Focal Cartilage Defects of the Knee: A Systematic Review of the Literature and Study Quality Analysis.](https://pubmed.ncbi.nlm.nih.gov/27655978/). *The Journal of bone and joint surgery. American volume*, 2016. DOI: 10.2106/JBJS.15.01495. 5. The study that first mapped the scale of the US direct-to-consumer stem cell industry, finding widespread internet marketing of unapproved stem cell interventions by businesses based in the UNITED STATES - previously assumed to be a phenomenon of countries with lax medical regulation - and concluding that regulators must better oversee this marketplace. Turner L, et al. — [Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry.](https://pubmed.ncbi.nlm.nih.gov/27374789/). *Cell stem cell*, 2016. DOI: 10.1016/j.stem.2016.06.007. ## An exam can find the sore part If soreness keeps limiting sleep or daily use, an exam may find the likely cause. Bring an old scan and the questions that matter to you. Book an appointment: --- What may help a sore shoulder Practical answers about a shoulder ache, simple self-care, urgent symptoms, treatment questions, and a Scottsdale visit. Practical information about shoulder aches, simple self-care, urgent symptoms, and local options. For transparency, this site is run by the owners of QC Kinetix's Phoenix-area clinics. © 2026 Scottsdale Shoulder Fieldbook. Educational information, not individual medical advice.